citalopram has been researched along with sertraline in 316 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 25 (7.91) | 18.2507 |
| 2000's | 97 (30.70) | 29.6817 |
| 2010's | 145 (45.89) | 24.3611 |
| 2020's | 49 (15.51) | 2.80 |
| Authors | Studies |
|---|---|
| Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J | 1 |
| Caccia, S; Casini, A; Scozzafava, A; Supuran, CT | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Bagale, SM; Brown, AS; Gonzalez, MM; Hentall, ID; Kumar, NS; Micotto, TL; Vitores, A; Wilson, JN | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J | 1 |
| Maj, J; Moryl, E | 1 |
| Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR | 1 |
| Baumann, P; Rochat, B | 1 |
| Auerbach, SB; Hjorth, S; Lundberg, JF | 1 |
| Hyttel, J; Sánchez, C | 1 |
| Harnett-Sheehan, K; Sheehan, DV | 1 |
| Baumann, P; Eap, CB | 1 |
| Meier, E; Sánchez, C | 1 |
| Earley, B; Faherty, CJ; Leonard, BE | 1 |
| Bouwer, CD; Hawkridge, SM; Stein, DJ | 1 |
| Mellerup, ET; Plenge, P | 1 |
| Bouwer, C; Stein, DJ; van Heerden, B | 1 |
| Eberhard, G; Ekselius, L; von Knorring, L | 1 |
| Amey, M; Baumann, P; Bouchoux, G; Cochard, N; Eap, CB; Savary, L | 1 |
| Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Barbey, JT; Roose, SP | 1 |
| Ekselius, L; von Knorring, L | 3 |
| Stahl, SM | 2 |
| Dekeyne, A; Girardon, S; Gobert, A; Millan, MJ | 1 |
| Anand, VS; Dewan, MJ | 1 |
| Meyers, BS | 1 |
| Carleborg, L; Hägg, S; Ohman, R; Spigset, O | 1 |
| Bakker, A | 1 |
| Härtter, S; Hiemke, C | 1 |
| Bengtsson, F; Ekselius, L; von Knorring, L | 1 |
| Buzinkaiová, T; Polonský, J | 1 |
| Baumann, P; Hodel, PF; Voirol, P; Zullino, D | 1 |
| Bergsholm, YK; Bøhler, E; Nordeng, H; Spigset, O | 1 |
| Burt, T; Lane, RM | 1 |
| Kruizinga, M; Ramaekers, JG; Riedel, WJ; Schmitt, JA; Vuurman, EF | 1 |
| Brown, EB; Gonzales, JS; Miner, CM; Munir, R | 1 |
| Cullen, N; Lexell, J; Zafonte, RD | 1 |
| Droogmans, G; Maertens, C; Nilius, B; Verbesselt, R | 1 |
| Boyle, P; Correia, S; Krishnan, KR; Lavretsky, H; Malloy, P; Roose, S; Sackheim, H; Salloway, S; Schneider, L | 1 |
| Anderson, TA; Dobscha, SK; Hauser, P; Hoffman, WF; Snodgrass, LS; Turner, EH; Winterbottom, LM | 1 |
| Levenson, JL | 1 |
| Altshuler, LL; Haynes, D; Hendrick, V; Hwang, S; Lee, E; Stowe, ZN | 1 |
| Czarnecka, E; Pietrzak, B | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Burgin, C; Jones, DE; Masters, BK; Parker, DE; Potter-Kimball, R; Tucker, P; Wyatt, DB | 1 |
| Akin, A; Chaturvedi, AK | 1 |
| Baker, GB; Fletcher, PJ; Salsali, M; Sinyard, J | 1 |
| Eaddy, MT; Grudzinski, AN; McLaughlin, TP | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Carella, A; Cheok, A; Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Potter, WZ; Sagrati, S; Spencer, EP; Wilson, AA | 1 |
| Cryan, JF; Dalvi, A; Friedland, JC; Hirsch, BR; Jin, SH; Lucki, I; O'Leary, OF; Ouyang, M; Page, ME; Thomas, SA | 1 |
| Hossain, A; Masters, B; Parker, DE; Ruwe, WD; Trautman, RP; Tucker, P; Wyatt, DB | 1 |
| Brown, EB; Joliat, MJ; Miner, CM | 1 |
| Eichner, SF; Jones, JR; Moore, ML | 1 |
| Modestin, J; Tomaselli, G | 1 |
| Armbrust, KL; Black, MC; Henry, TB; Kwon, JW | 1 |
| Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
| Elfving, B; Wiborg, O | 1 |
| Eikmans, K; Heldens, A; Riedel, WJ; Schmitt, JA | 1 |
| Bogetto, F; Calvarese, P; Faggiano, F; Marchiaro, L; Mathis, F; Rivoira, E; Rocca, P; Taricco, B | 1 |
| Altindag, A; Asoglu, M; Yanik, M | 1 |
| Harrison, D; Meng, F; Mullins, CD; Shaya, FT; Wang, J | 1 |
| Bastiaens, L | 1 |
| Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
| Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM | 1 |
| Lambert, WE; Maudens, KE; Van Peteghem, CH; Wille, SM | 1 |
| Carrasco, JL; Sandner, C | 1 |
| Giordani, S; Lucca, A; Magri, L; Rossini, D; Smeraldi, E; Zanardi, R | 1 |
| Ibrahim Ramadan, M; Khan, AY; Weston, WE | 1 |
| Berger, U; Jensen, E; Kallenborn, R; Samuelsen, PJ; Vasskog, T | 1 |
| Akarsu, ES; Ayhan, IH; Cankurtaran, ES; Cekic, T; Ozalp, E; Palaoglu, O; Soygur, H; Turhan, L | 1 |
| Csoka, AB; Shipko, S | 1 |
| Bron, MS; Meng, F; Mullins, CD; Shaya, FT; Wang, J | 1 |
| Hedenmalm, K; Spigset, O; Sundström, A | 1 |
| Kapetanovic, S; Simpson, GM | 1 |
| Greenhill, LL; Moreno, C; Roche, AM | 1 |
| Ayestarán, A; Carrera, M; García-Unzueta, MT; Herrán, A; Hoyuela, F; Ramírez, ML; Rodríguez-Cabo, B; Sierra-Biddle, D; Vázquez-Barquero, JL | 1 |
| Bailly, D | 1 |
| Haro, JM; Peñarrubia, MT; Pinto-Meza, A; Serrano-Blanco, A; Suárez, D | 1 |
| Chiricolo, G; Cola, C; Di Lorenzo, G; Forleo, GB; Lauro, R; Leo, R; Razzini, C; Romeo, F; Siracusano, A; Tesauro, M; Troisi, A; Zanasi, M | 1 |
| Baker, B; Burt, T; Desta, Z; Flockhart, D; Greenblatt, DJ; Harmatz, JS; Klick-Davis, A; Luo, Y; Perloff, ES; Preskorn, SH | 1 |
| Armstrong, EP; Haim Erder, M; Skrepnek, GH; Ventura, D | 1 |
| Armstrong, EP; Haim Erder, M; Skrepnek, GH | 1 |
| Ziegelstein, RC | 1 |
| Boovariwala, A; Ginovart, N; Houle, S; Meyer, JH; Rusjan, P; Sagrati, S; Sokolov, S; Spencer, EP; Voineskos, AN; Wilson, AA | 1 |
| Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G | 1 |
| Markowitz, JD | 1 |
| Görker, I; Hergüner, S; Kilinçaslan, A; Tüzün, U | 1 |
| Hetrick, S; McKenzie, J; Merry, S; Proctor, M; Sindahl, P | 1 |
| Badyal, DK; Deswal, RS; Khosla, P; Matreja, PS | 1 |
| Brooks, BW; Frazer, A; Gould, GG | 1 |
| Drago, F; Leggio, GM; Micale, V | 1 |
| Bekele, NB; Shih, YC; Xu, Y | 1 |
| Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME | 1 |
| Shelton, RC | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Croft, RJ; Guille, V; Illic, S; Nathan, PJ; O'Neill, BV; Phan, KL | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Helsel, JC; Perel, JM; Sit, DK; Wisner, KL | 1 |
| Beekman, AT; Comijs, HC; Deeg, DJ; Sonnenberg, CM; van Tilburg, W | 1 |
| Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R | 1 |
| Akgül, T; Ayyildiz, A; Germiyanoğlu, C; Karakan, T | 1 |
| Mizrahi, R; Power, BD; Starkstein, SE | 1 |
| Bonaccorso, S; Girardi, P; Matrisciano, F; Nicoletti, F; Panaccione, I; Ricciardi, A; Ruberto, A; Scaccianoce, S; Shelton, RC; Tatarelli, R; Wang, L | 1 |
| Brennum, LT; Kreilgaard, M; Sánchez, C; Smith, DG | 1 |
| Itakura, C; Katayama, M; Niimi, K; Takahashi, E | 1 |
| Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Ikonomidis, I; Kremastinos, DT; Lekakis, J; Moutsatsou, P; Nikolaou, M; Papoutsi, Z; Parissis, J | 1 |
| Dotan, Y; Pillar, G; Suraiya, S | 1 |
| Brooks, DE; Pizon, AF; Schwartz, AR | 1 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| Gale, CK; Millichamp, J | 1 |
| Arciniegas, DB; McAllister, TW; Silver, JM | 1 |
| Carrilho, E; Catai, AP; Lanças, FM; Queiroz, ME | 1 |
| De Koning, FH; Derijks, HJ; Egberts, AC; Heerdink, ER; Janknegt, R; Krekels, MM; Looij, BJ | 1 |
| Lanza di Scalea, T; Wisner, KL | 1 |
| Hoge, EA; Lebeau, RT; Moshier, SJ; Otto, MW; Pollack, MH; Simon, NM; Thompson, EH; Worthington, JJ; Zalta, AK | 1 |
| Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ | 1 |
| Baumer, C; Koren, G; O'Brien, L; Sachs, H; Thieme, D | 1 |
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Charles, D; Fava, M; Papakostas, GI | 1 |
| Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS | 1 |
| Burgess, PM; Hollingworth, SA; Whiteford, HA | 1 |
| Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 3 |
| Mochcovitch, MD; Nardi, AE | 1 |
| Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M | 1 |
| Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
| Halling-Sørensen, B; Ingerslev, F; Styrishave, B | 1 |
| Dobzhenko, MN; Shchepotin, IB; Zotov, AS | 1 |
| Cooper, NJ; Gordon, E; Koslow, SH; Nemeroff, CB; Rush, AJ; Schatzberg, AF; Williams, LM; Wisniewski, SR | 1 |
| Ahmed, AH; Calvird, M; Gordon, RD; Pimenta, E; Stowasser, M; Taylor, PJ; Ward, G; Young, R | 1 |
| Kardeh, E; Mowla, A | 1 |
| Barber, GR; Barron, MA; Go, AC; Golightly, LK | 1 |
| Dadić-Hero, E; Grahovac, T; Graovac, M; Palijan, TZ; Ružić, K; Sepić-Grahovac, D | 1 |
| Beste, J; Blackwell, JC; Patel, BN | 1 |
| Burke, HM; Epel, ES; Lerner, GK; Mellon, SH; Nelson, JC; Reus, VI; Rosser, R; Shelly, W; Wolf, J; Wolkowitz, OM | 1 |
| Chen, YS; Chou, YH; Hsu, JW; Huang, CY; Su, TP | 1 |
| Abe, T; Hirano, J; Kashima, H; Mimura, M; Nakajima, S; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K; Yagihashi, T | 1 |
| Bisgaard, CF; Christensen, T; Wiborg, O | 1 |
| Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
| Chamielec, M; Gałecki, P; Talarowska, M; Zboralski, K | 1 |
| Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T | 1 |
| Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA | 1 |
| Cerit, C; Isik, S; Ozten, E; Tufan, AE | 1 |
| Cortés, JM; Hidalgo, M; Jönsson, JÅ; Larsson, E; Sagristà, E; Salvadó, V | 1 |
| Leelahanaj, T | 1 |
| Karaiskos, D; Paparrigopoulos, T; Spengos, K; Tzavellas, E; Vassilopoulou, S | 1 |
| Fava, M; Perlis, RH; Perroud, N; Uher, R | 1 |
| Alagille, D; Barret, O; Batis, J; Cosgrove, K; Goodman, M; Koren, AO; Seibyl, J; Stehouwer, JS; Tamagnan, G | 1 |
| Eriksson, AC; Hägg, S; Hallbäck, I; Whiss, PA | 1 |
| Aagaard, L; Andersen, SE; Glintborg, D; Moreno, SI; Poulsen, KK; Thirstrup, S | 1 |
| Bak, S; Bisgaard, CF; Christensen, T; Enghild, JJ; Jensen, ON; Wiborg, O | 1 |
| Cox, GR; Hetrick, SE; McKenzie, JE; Merry, SN; Simmons, MB | 1 |
| Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE | 1 |
| Kováru, F; Kovárů, H; Lisá, V | 1 |
| Almeida, JR; Axelson, DA; Birmaher, B; Diler, RS; Ladouceur, CD; Pan, LA; Phillips, ML; Segreti, A | 1 |
| Corruble, E; Demyttenaere, K; Hale, A; Kasper, S; Picarel-Blanchot, F; Quera-Salva, MA | 1 |
| Kaplan, C; Zhang, Y | 1 |
| Gorman, DA; Lam, D; Patten, S; Pringsheim, T | 1 |
| Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR | 1 |
| Blow, FC; Bohnert, AS; Ganoczy, D; Kales, HC; Nallamothu, BK; Pfeiffer, PN; Zivin, K | 1 |
| Etkin, A; Gordon, E; Grieve, SM; Harris, A; Korgaonkar, MS; Koslow, SH; Nemeroff, CB; Schatzberg, AF; Williams, LM; Wisniewski, S | 1 |
| Park, YM | 1 |
| Cho, HY; Kim, JE; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Seo, MK; Seol, W | 1 |
| Dixit, S; Park, JH | 1 |
| Montgomery, SA; Reines, EH; Sanchez, C | 1 |
| Damkier, P; Hallas, J; Pottegård, A; Zoëga, H | 1 |
| Park, JH; Park, JM | 1 |
| Cooper, N; Gross, JJ; McRae, K; Rekshan, W; Williams, LM | 1 |
| Gjestad, C; Skogvoll, E; Spigset, O; Westin, AA | 1 |
| Handley, AP; Williams, M | 1 |
| Clarke, W; Jannetto, PJ; Johnson-Davis, KL; Langman, LJ; Marzinke, MA; Moskowitz, J; Petrides, AK | 1 |
| Becker, T; Koesters, M; Ma, Y; Zhang, Y | 1 |
| Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
| Hassanpour Moghadam, M; Mohajeri, SA; Sajadi Tabassi, SA; Talaei, A | 1 |
| IsHak, WW; Karamians, R; Peselow, ED; Pizano, D; Tobia, G | 1 |
| Etkin, A; Patenaude, B; Rekshan, W; Rush, AJ; Schatzberg, AF; Song, YJ; Usherwood, T; Williams, LM | 1 |
| Arnow, BA; Boyce, PM; Day, CV; DeBattista, C; Etkin, A; Harris, AW; John Rush, A; Rekshan, W; Schatzberg, AF; Williams, LM | 1 |
| Hermann, M; Molden, E; Waade, RB | 1 |
| Demyttenaere, K; Dunbar, G; Eriksson, H; Hosford, D; Möller, HJ; Olausson, B; Szamosi, J; Tummala, R; Wilson, E | 1 |
| Dueñas, H; Haro, JM; Hong, J; Moneta, MV; Montgomery, W; Novick, D; Peng, X | 1 |
| Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM | 1 |
| DeBattista, C; Etkin, A; Lazzeroni, LC; Murphy, GM; Schatzberg, AF; Williams, LM | 1 |
| Etkin, A; Grieve, SM; Gyurak, A; Korgaonkar, MS; Patenaude, B; Williams, LM | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D | 1 |
| Arns, M; DeBattista, C; deBeuss, R; Etkin, A; Fitzgerald, PB; Gordon, E; Harris, A; Hegerl, U; Palmer, DM; Williams, LM | 1 |
| Halling-Sørensen, B; Hansen, CH; Jacobsen, NW; Nellemann, C; Styrishave, B | 1 |
| McMahon, FJ | 1 |
| Arns, M; Debattista, C; Fallahpour, K; Fitzgerald, P; Gordon, E; Jongsma, ML; Kenemans, L; Kessels, RP; van Dinteren, R; Williams, LM | 1 |
| Patterson, B; Van Ameringen, M | 1 |
| Egashira, N; Kuwahara, J; Masuda, S; Ueda, M; Ushio, S; Yamada, T; Zukeyama, N | 1 |
| Berk, M; Collier, FM; Dodd, S; Ellis, M; Fraher, D; Gibert, Y; Hodge, JM; Kennedy, RL; McMillan, JS; Nicholson, GC; Pasco, JA; Walder, K; Williams, LJ | 1 |
| Licata, M; Lusetti, M; Palmiere, C; Reggiani Bonetti, L; Silingardi, E | 1 |
| Bloch, MH; Freemantle, N; Jakubovski, E; Taylor, MJ; Varigonda, AL | 1 |
| Azrael, D; Bushnell, GA; Miller, M; Pate, V; Stürmer, T; Swanson, SA; White, A | 1 |
| Arns, M; Boutros, NN; Gordon, E | 1 |
| Citrome, L | 1 |
| Etkin, A; Gyurak, A; Harris, A; Shilyansky, C; Usherwood, T; Williams, LM | 1 |
| Arakawa, R; Kim, W; Ogawa, K; Okubo, Y; Sakayori, T; Tateno, A | 1 |
| Gordon, E; Grieve, SM; Korgaonkar, MS; Rush, AJ; Williams, LM | 1 |
| Craig, JC; Natale, P; Palmer, SC; Rabindranath, KS; Ruospo, M; Saglimbene, VM; Strippoli, GF | 1 |
| Andreão, RV; Benseñor, IM; Bittencourt, MS; Brunoni, AR; Dantas, EM; Fráguas, R; Kemp, AH; Koenig, J; Lotufo, PA; Mill, JG; Nunes, MA; Ribeiro, AL; Thayer, JF | 1 |
| Eriksson, E; Hieronymus, F; Nilsson, S | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Brawman-Mintzer, O; Dauphin, M; Gao, J; Geibel, B; Madhoo, M; McIntyre, RS; Richards, C; Sambunaris, A; Weisler, R | 1 |
| Li, Y; Lu, X; Tao, C; Yan, W | 1 |
| Brooks, MM; Luther, JF; Potter, MA; Roberts, MS; Singh, A; Voorhees, RE; Wisniewski, SR | 1 |
| DeLucia, V; Kelsberg, G; Safranek, S | 1 |
| Gresky, DP; Ruble, MW; Treviño, K; Treviño, LA; Weinstein, LM | 1 |
| Cates, C; Norton, DJ | 1 |
| Buysse, DJ; Edinger, JD; Fairholme, CP; Gehrman, P; Krystal, AD; Luther, J; Manber, R; Thase, ME; Wisniewski, S | 1 |
| Brose, SA; Golovko, MY; Henry, LK; Krout, D; Rodriquez, M; Thompson, BJ | 1 |
| Chen, J; Deng, X; Fang, L; Lei, T; Lei, Y; Qu, Z; Zhang, L; Zhao, X; Zhong, J; Zhou, C; Zou, B | 1 |
| Araujo, M; Benevent, J; Bondon-Guitton, E; Chebane, L; Durrieu, G; Montastruc, F; Montastruc, JL; Ojero-Senard, A | 1 |
| Emilsson, JF; Eriksson, E; Hieronymus, F; Lisinski, A; Näslund, J; Nilsson, S | 1 |
| Kamagata, E; Yamada, K | 1 |
| Gerlach, LB; Kales, HC; Kim, HM; Sales, AE; Stano, C; Yosef, M; Zivin, K | 1 |
| Broadhouse, K; Gordon, E; Grieve, SM; Koslow, S; Maller, JJ; Rush, AJ | 1 |
| Dastgheib, SA; Modarresi, F; Mowla, A | 1 |
| Binder, EB; Carrillo-Roa, T; Craighead, WE; Debattista, C; Dunlop, BW; Goldstein-Piekarski, AN; Mayberg, HS; Nemeroff, CB; O'Connell, CP; Schatzberg, AF; Williams, LM | 1 |
| Johansen, SS; Linnet, K; Nedahl, M | 1 |
| Katsanos, AH; Paraschakis, A | 1 |
| Bogdanova, OV; D'Anci, KE; Kanekar, S; Olson, PR; Ombach, HJ; Petersen, M; Renshaw, CE; Renshaw, PF; Sheth, CS; Sung, YH | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Gerlach, LB; Henry, J; Kales, HC; Kim, HM; Yosef, M; Zivin, K | 1 |
| Augustin, M; Franz, C; Gründer, G; Paulzen, M; Saßmannshausen, H; Schoretsanitis, G | 1 |
| de Koning, PP; Denys, D; van Bennekom, MJ | 1 |
| Baskak, B; Demirbugen Oz, M; Devrimci Ozguven, H; Kizil Ozel, T; Ozdemir, H; Suzen, HS; Uckun, Z; Yuce-Artun, N | 1 |
| Gao, YL; He, B | 1 |
| Gotlib, IH; Kircanski, K; Williams, LM | 1 |
| Johansen, SS; Linnet, K; Nielsen, MKK; Wang, X | 1 |
| Barbui, C; Caruso, R; Gastaldon, C; Grassi, L; Hotopf, M; Ostuzzi, G; Papola, D; Rayner, L; Turrini, G | 1 |
| Bohn, J; Connolly, JG; Dejene, S; Desai, RJ; Dutcher, SK; Fischer, MA; Gagne, JJ; Kesselheim, AS; Khan, NF; Lii, J; Raofi, S; Rogers, JR; Sarpatwari, A | 1 |
| Aitchison, KJ; Binder, EB; Carrillo-Roa, T; Cattaneo, A; DeModena, A; Henigsberg, N; Kelsoe, JR; Leckband, SG; Liu, JJ; McCarthy, M; Mors, O; Ren, H; Rietschel, M; Shekhtman, T; Wei, YB | 1 |
| Assimon, MM; Brookhart, MA; Flythe, JE | 1 |
| Barbui, C; Bennie, M; Godman, B; Hurding, S; Johnson, CF; Kurdi, A; Leporowski, A; MacBride-Stewart, S; McCabe, H; Morton, A | 1 |
| Braund, TA; Harris, AWF; Palmer, DM; Williams, LM | 1 |
| Bajbouj, M; Cooper, K; Daly, EJ; Drevets, WC; Hough, D; Lane, R; Lim, P; Manji, H; Mazzucco, C; Molero, P; Popova, V; Shelton, RC; Singh, JB; Thase, ME; Trivedi, M; Vieta, E | 1 |
| Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA | 1 |
| Chen, L; Cheng, S; Guo, S; Xu, H | 1 |
| Bacon, F; Clarke, CS; Donkor, Y; Duffy, L; Freemantle, N; Gilbody, S; Hunter, R; Kendrick, T; Kessler, D; King, M; Lanham, P; Lewis, G; Mangin, D; Marston, L; Moore, M; Nazareth, I; Wiles, N | 1 |
| Baldwin, DS; Chen, X; Fu, J; Fu, T; Gao, Z; Hou, R; Liu, Q; Liu, Y; Pan, M; Tang, Z; Ye, G; Zhu, F | 1 |
| Alexander, MS; Berg, JS; Chahin, N; Draper, I; Finkel, RS; Hightower, RM; Kang, PB; Pacak, CA; Ramanathan, M; Rizzo, SA; Saha, M; Santostefano, KE; Terada, N; Wagner, RE | 1 |
| Ameele, HVD; Blier, P; Daly, EJ; Drevets, WC; Fava, M; Fedgchin, M; Gaillard, R; Hough, D; Lane, R; Liebowitz, M; Lim, P; Manji, H; Melkote, R; Preskorn, S; Ravindran, A; Singh, JB; Trivedi, M; Vitagliano, D | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Nilsson, S | 1 |
| Alag, P; Balasubramaniam, M; Gupta, A; Gupta, S; Joshi, P; Maher, S; Tampi, D; Tampi, RR; Young, J | 1 |
| Arns, M; Boutros, NN; Fallahpour, K; van der Vinne, N; van Putten, MJAM; Vollebregt, MA | 1 |
| Doucet, N; Hudon Thibeault, AA; López de Los Santos, Y; Sanderson, JT; Vaillancourt, C | 1 |
| Abbaszadegan, MR; Ahmadimanesh, M; Akhondpour Manteghi, A; Behdani, F; Etemad, L; Farid Hosseini, F; Ghahremani, MH; Jowsey, P; Moallem, SA; Moallem, SMH; Mohammadpour, AH; Morshedi Rad, D; Shabani Behbahani, F | 1 |
| Bishop, JR; Bousman, CA; Caudle, KE; Gaedigk, A; Gammal, RS; Hicks, JK; Klein, TE; Leeder, JS; Llerena, A; Mueller, DJ; Ramsey, LB; Sangkuhl, K; Scott, SA; Skaar, TC | 1 |
| Fornito, A; Goldstein-Piekarski, AN; Korgaonkar, MS; Williams, LM | 1 |
| Artun, NY; Baskak, B; Oz, MD; Ozdemir, H; Ozel, TK; Ozguven, HD; Suzen, HS; Uckun, Z | 1 |
| Arns, M; van der Vinne, N; van Putten, MJAM; Vollebregt, MA | 1 |
| Cabrera, RM; Kim, J; Law, E; Linda Lin, Y; Wlodarczyk, BJ | 1 |
| Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X | 1 |
| Aguglia, E; Migliore, M; Signorelli, MS; Surace, T | 1 |
| Frecska, E; Mathe, E; More, C; Szoke-Kovacs, R; Szoke-Kovacs, Z | 1 |
| Abe, K; Hishikawa, N; Matsumoto, N; Nomura, E; Ohta, Y; Omote, Y; Sasaki, R; Tadokoro, K; Takemoto, M; Tsunoda, K; Yamashita, T | 1 |
| Basu, S; Dass, N; Irvin, J; Keller, AS; Ng, A; Rajpurkar, P; Taylor, Z; Vale, V; Williams, LM; Yang, J | 1 |
| Flannagan, KS; Kim, K; Mumford, SL; Perkins, NJ; Radoc, JG; Schisterman, EF; Silver, RM; Sjaarda, LA | 1 |
| Beltrán, CJ; Bravo, JA; Escobar-Luna, J; Eyzaguirre-Velásquez, J; González-Arancibia, C; González-Toro, MP; Julio-Pieper, M | 1 |
| Hui, A | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Wallerstedt, SM | 1 |
| Bigos, KL; Brasic, J; Dannals, RF; Gould, NF; Hall, AW; Holt, DP; Joo, JH; Kraut, M; Kuwabara, H; Mathews, WB; Nandi, A; Nassery, N; Savonenko, A; Smith, GS; Workman, CI | 1 |
| Aladaghlo, Z; Fakhari, AR; Javanbakht, S; Shaabani, A | 1 |
| Avramopoulos, D; Brasic, J; Dannals, RF; Gould, NF; Hall, AW; Holt, DP; Joo, JH; Kraut, M; Kuwabara, H; Mathews, WB; Nandi, A; Nassery, N; Savonenko, A; Smith, GS; Workman, CI | 1 |
| Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
| Anagha, K; Shihabudheen, P; Uvais, NA | 1 |
| Braund, TA; Gordon, E; Harris, AWF; Palmer, DM; Rush, AJ; Tillman, G | 1 |
| Hanna, K; Hatch, L; Herr, J; Sephien, A | 1 |
| Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E | 1 |
| Baugh, TB; Carr, CN; Reed, E; Sochacki, M; Straley, CM | 1 |
| Hsu, CW; Kao, HY; Lin, PY; Tseng, WT; Wang, LJ; Yang, YH | 1 |
| Kalisch Ellett, LM; Kassie, GM; Nguyen, TA; Pratt, NL; Roughead, EE | 1 |
| Aghaeepour, N; Maric, I; Oskotsky, B; Oskotsky, T; Sirota, M; Stevenson, DK; Tang, A; Wong, RJ | 1 |
| Brouwer, JMJL; Buunk, AM; de Boer-Veger, NJ; Deneer, VHM; Guchelaar, HJ; Houwink, EJF; Mulder, H; Nijenhuis, M; Rongen, GAPJM; Soree, B; Swen, JJ; van Schaik, RHN; van Westrhenen, R; Weide, JV; Wilffert, B | 1 |
| Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA | 1 |
| Haddad, YK; Kakara, R; Marcum, ZA | 1 |
| Brener, I; Gil-Ad, I; Hornfeld, SH; Taler, M; Weizman, A | 1 |
| Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC | 2 |
| Camino, S; Godoy, A; Smith, J; Strejilevich, SA; Szmulewicz, A | 1 |
| Cipelli, R; Dell'Osso, B; Di Nicola, M; Martinotti, G; Peduto, I; Pugliese, AC; Signorelli, MS; Ventriglio, A | 1 |
| Giraldi, A; Hutters, CL | 1 |
| Bracke, F; Frieling, H; Leffler, A | 1 |
| Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S | 1 |
| Adams, RJ; Leoutsakos, JM; Lyketsos, CG; Wise, EA | 1 |
| Azoulay, L; Cao, TXD; Fergusson, E; Filliter, C; Montastruc, F; Rej, S; Renoux, C; Yu, OHY | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Esfahani, H; Golbaz, S; Nabizadeh, R; Rastkari, N; Yaghmaeian, K; Zamanzadeh, M | 1 |
| Geng, J; Ren, H; Wang, X; Wang, Y; Wei, S; Wu, G; Yu, Q; Zhang, X | 1 |
| Asadi-Pooya, AA; Firouzabadi, N; Kashkooli, M; Malekpour, M; Zamiri, B | 1 |
| Burzio, C; Malmberg, P; Modin, O; Mohammadi, AS; Persson, F; Wilén, BM | 1 |
| Christensen, KS; Gasse, C; Ishtiak-Ahmed, K | 1 |
| Boyce, P; Galbally, M; Nguyen, T; Watson, SJ | 1 |
| Chroňáková, A; Fedorova, G; Fér, M; Grabic, R; Klement, A; Kočárek, M; Kodešová, R; Nikodem, A; Rieznyk, O; Sadchenko, A; Švecová, H | 1 |
51 review(s) available for citalopram and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries | 2020 |
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism | 1995 |
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
SSRI safety in overdose.
Topics: Adult; Child; Citalopram; Drug Overdose; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Poison Control Centers; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1998 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Pharmacokinetics of selective serotonin reuptake inhibitors.
Topics: Citalopram; Clinical Trials as Topic; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Serotonin agents in the treatment of acquired brain injury.
Topics: Brain Injuries; Citalopram; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Injury Severity Score; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
Topics: Autistic Disorder; Citalopram; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Fluoxetine; Fluvoxamine; Humans; Mood Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Pharmacotherapy of child and adolescent depression.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Sertraline; Social Behavior | 2006 |
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted | 2006 |
Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2007 |
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2008 |
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2008 |
Antidepressant therapy in post-stroke depression.
Topics: Antidepressive Agents; Citalopram; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Nortriptyline; Prognosis; Sertraline; Stroke; Treatment Outcome | 2008 |
Generalised anxiety disorder.
Topics: Anxiety Disorders; Citalopram; Cognitive Behavioral Therapy; Double-Blind Method; Humans; Paroxetine; Remission Induction; Sertraline | 2007 |
Depression and cognitive complaints following mild traumatic brain injury.
Topics: Antidepressive Agents, Tricyclic; Brain; Brain Injuries; Central Nervous System Stimulants; Choline; Citalopram; Cognition Disorders; Cognitive Behavioral Therapy; Depression; Humans; Methylphenidate; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2009 |
Antidepressant medication use during breastfeeding.
Topics: Antidepressive Agents, Second-Generation; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Humans; Infant; Lactation; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
Topics: Citalopram; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens | 2010 |
[Selective serotonin reuptake inhibitors and mammary pathologies].
Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride | 2012 |
Newer generation antidepressants for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Induction Chemotherapy; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2012 |
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation | 2012 |
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Topics: Allosteric Site; Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder, Major; Drug Interactions; Evidence-Based Medicine; Humans; Models, Biological; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2014 |
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride | 2015 |
A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; China; Citalopram; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride | 2015 |
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2016 |
Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Vilazodone Hydrochloride | 2016 |
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Fluoxetine; Humans; Kidney Failure, Chronic; Psychotherapy; Quality of Life; Randomized Controlled Trials as Topic; Renal Dialysis; Sertraline | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Humans; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Venlafaxine Hydrochloride | 2017 |
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Citalopram; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Antidepressants for Depression Associated with Traumatic Brain Injury: A Meta-analytical Study of Randomised Controlled Trials.
Topics: Antidepressive Agents; Brain Injuries, Traumatic; Citalopram; Depression; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome | 2017 |
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Humans; Myocardial Ischemia; Quality of Life; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2019 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2019 |
Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Asian People; Cardiovascular Diseases; China; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Antidepressants for anxiety disorders in late-life: A systematic review.
Topics: Aged; Antidepressive Agents; Anxiety Disorders; Citalopram; Duloxetine Hydrochloride; Humans; Late Onset Disorders; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Mood disorders and outcomes in lung cancer patients undergoing surgery: a brief summery.
Topics: Anxiety; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Humans; Lung Neoplasms; Patient Care Team; Pneumonectomy; Postoperative Complications; Quality of Life; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide, Attempted; Survival Rate; Treatment Outcome | 2020 |
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain.
Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome | 2020 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Are all antidepressants the same? The consumer has a point.
Topics: Antidepressive Agents; Bupropion; Citalopram; Fluoxetine; Humans; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2023 |
[Sexual side effects from treatment with SSRI].
Topics: Citalopram; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
73 trial(s) available for citalopram and sertraline
| Article | Year |
|---|---|
A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Diarrhea; Double-Blind Method; Family Practice; Female; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 1997 |
Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Disorders; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Changes in personality traits during treatment with sertraline or citalopram.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Personality; Personality Assessment; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Impulsive Behavior; Male; Middle Aged; Patient Compliance; Personality; Personality Assessment; Sertraline | 2000 |
Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
Topics: Adult; Citalopram; Depressive Disorder; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2000 |
Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care.
Topics: Adult; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Statistics, Nonparametric | 2001 |
Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes.
Topics: Adult; Analysis of Variance; Citalopram; Cross-Over Studies; Double-Blind Method; Female; Flicker Fusion; Humans; Male; Middle Aged; Mydriasis; Pupil; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2002 |
MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression.
Topics: Age of Onset; Aged; Aging; Antidepressive Agents, Second-Generation; Brain; Citalopram; Dementia, Vascular; Depressive Disorder; Female; Humans; Magnetic Resonance Imaging; Male; Outpatients; Psychiatric Status Rating Scales; Risk Factors; Sertraline; Treatment Outcome | 2002 |
Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo.
Topics: Adolescent; Adult; Citalopram; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2003 |
Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder.
Topics: Adult; Chronic Disease; Circadian Rhythm; Citalopram; Double-Blind Method; Female; Humans; Hydrocortisone; Interleukin-1; Male; Middle Aged; Neuroimmunomodulation; Receptors, Interleukin-2; Reference Values; Saliva; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic | 2004 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment.
Topics: Adult; Affect; Arousal; Circadian Rhythm; Citalopram; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Characteristics; Sleep; Verbal Learning | 2005 |
Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.
Topics: Age Factors; Aged; Citalopram; Cognition Disorders; Depressive Disorder; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Trail Making Test; Treatment Outcome; Wechsler Scales | 2005 |
Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.
Topics: Adult; Citalopram; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.
Topics: Adult; Biomarkers; CD40 Ligand; Citalopram; Depressive Disorder, Major; Factor VIIa; Female; Humans; Inflammation; Interleukin-1beta; Male; P-Selectin; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; Up-Regulation | 2006 |
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers.
Topics: Adult; Antidepressive Agents; Citalopram; Cytochrome P-450 CYP2D6; Drug Interactions; Duloxetine Hydrochloride; Female; Humans; Male; Metoprolol; Middle Aged; Reference Values; Sertraline; Single-Blind Method; Thiophenes | 2007 |
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2007 |
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
Topics: Adult; Antidepressive Agents; Citalopram; Corpus Striatum; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2007 |
Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.
Topics: Adult; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; India; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2007 |
An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline.
Topics: Adolescent; Adult; Affect; Auditory Cortex; Behavior; Citalopram; Cross-Over Studies; Double-Blind Method; Evoked Potentials, Auditory; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission | 2008 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression, Postpartum; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2008 |
Comparison of sertraline and citalopram for treatment of premature ejaculation.
Topics: Adult; Citalopram; Ejaculation; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 2008 |
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cyclohexanols; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
Topics: Adult; Aged; Aorta; Cell Adhesion; Cell Survival; Chronic Disease; Citalopram; Depression; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Fluvoxamine; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Monocytes; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2010 |
Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
Topics: Adult; Anticonvulsants; Citalopram; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Female; Humans; Longitudinal Studies; Male; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome | 2009 |
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cognition; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Electroencephalography; Emotions; Europe; Female; Humans; Male; Middle Aged; Neuropsychological Tests; New Zealand; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Behavior; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2011 |
Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients.
Topics: Adult; Aldosterone; Antidepressive Agents; Blood Pressure; Citalopram; Depression; Humans; Hydrocortisone; Hyperaldosteronism; Male; Renin; Renin-Angiotensin System; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2011 |
Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
Topics: Adult; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Fructose; Humans; Male; Neuroprotective Agents; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate | 2011 |
Serum BDNF levels before treatment predict SSRI response in depression.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cross-Over Studies; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2011 |
Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
Topics: Adult; China; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome; Young Adult | 2011 |
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Sertraline; Time Factors; Treatment Outcome | 2011 |
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.
Topics: Activities of Daily Living; Adult; Aged; Antidepressive Agents; Anxiety; Citalopram; Depression; Duloxetine Hydrochloride; Fatigue; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Sertraline; Stroke; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2012 |
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult | 2013 |
Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; California; Citalopram; Clinical Protocols; Cognition; Cyclohexanols; Depressive Disorder, Major; Diffusion Tensor Imaging; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; New South Wales; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Effects of antidepressant medication on emotion regulation in depressed patients: an iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Repression, Psychology; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2014 |
Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.
Topics: Adult; Carotenoids; Citalopram; Crocus; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Iran; Male; Middle Aged; Phytotherapy; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cognition; Computers; Delayed-Action Preparations; Depressive Disorder, Major; Emotions; Female; Humans; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Psychological Tests; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Risk Factors; Sertraline; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mecamylamine; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome; Young Adult | 2015 |
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Remission Induction; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Topics: Adult; Antidepressive Agents; Australia; Citalopram; Cognition; Depressive Disorder, Major; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Prefrontal Cortex; Prognosis; Psychiatric Status Rating Scales; Regression Analysis; Remission Induction; Sertraline; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2016 |
Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
Topics: Adult; Antidepressive Agents; Brain Mapping; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Gyrus Cinguli; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Severity of Illness Index; Theta Rhythm; Venlafaxine Hydrochloride | 2015 |
Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; Brain Mapping; Citalopram; Depressive Disorder, Major; Electroencephalography; Evoked Potentials; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Prospective Studies; Sertraline; Sex Characteristics; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression; Electroencephalography; Female; Humans; Internationality; Male; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2017 |
Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cognitive Dysfunction; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2016 |
Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
Topics: Adult; Antidepressive Agents; Brain; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nerve Net; Predictive Value of Tests; Psychiatric Status Rating Scales; Sertraline; Venlafaxine Hydrochloride; White Matter; Young Adult | 2016 |
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Least-Squares Analysis; Lisdexamfetamine Dimesylate; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Cost-Effective Drug Switch Options After Unsuccessful Treatment With an SSRI for Depression.
Topics: Adult; Bupropion; Citalopram; Cost-Benefit Analysis; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2017 |
Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.
Topics: Adult; Age of Onset; Antidepressive Agents; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Middle Aged; Sertraline; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; United States | 2017 |
Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
Topics: Adult; Age Factors; Antidepressive Agents; Citalopram; Cohort Studies; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Organ Size; Pattern Recognition, Automated; Prognosis; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Venlafaxine Hydrochloride | 2018 |
Comparing escitaloipram with sertraline for obsessive and compulsive symptoms in patients with obsessive compulsive disorder: A comparative double blind clinical trial.
Topics: Adult; Citalopram; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2018 |
Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Carrier Proteins; Citalopram; Depression; Female; Genotype; Homozygote; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2018 |
Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Biomarkers; Citalopram; Depression; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Prognosis; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2019 |
Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Citalopram; Cognition; Depressive Disorder, Major; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2020 |
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Topics: Administration, Intranasal; Administration, Oral; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Ketamine; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRes
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Depression; Double-Blind Method; Fluoxetine; Humans; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sample Size; Sertraline | 2019 |
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Antidepressive Agents; Citalopram; Delayed-Action Preparations; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Ketamine; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2019 |
Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
Topics: Adult; Alpha Rhythm; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression.
Topics: Adult; Case-Control Studies; Citalopram; Comet Assay; Depressive Disorder; DNA Damage; DNA Glycosylases; Female; Humans; Male; Middle Aged; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder.
Topics: Adult; Antidepressive Agents; Biomarkers; Brain; Citalopram; Connectome; Depressive Disorder, Major; Female; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Remission Induction; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2020 |
Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment.
Topics: Adult; Alpha Rhythm; Antidepressive Agents; Biomarkers; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Functional Laterality; Humans; Male; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Apathy; Citalopram; Depression; Female; Humans; Male; Nicergoline; Nootropic Agents; Prospective Studies; Sertraline; Single-Blind Method; Treatment Outcome | 2020 |
Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Topics: Adult; Algorithms; Antidepressive Agents; Citalopram; Clinical Decision Rules; Depressive Disorder, Major; Electroencephalography; Female; Humans; Machine Learning; Male; Middle Aged; Prognosis; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Humans; Sertraline; Treatment Outcome | 2021 |
Comparative effectiveness of antidepressants on geriatric depression: Real-world evidence from a population-based study.
Topics: Aged; Antidepressive Agents; Citalopram; Depression; Escitalopram; Humans; Sertraline; Treatment Outcome | 2022 |
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
192 other study(ies) available for citalopram and sertraline
| Article | Year |
|---|---|
Inhibition of P-glycoprotein by newer antidepressants.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection | 2003 |
Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and II.
Topics: Brain; Carbonic Anhydrase I; Carbonic Anhydrase II; Citalopram; Crystallography, X-Ray; Enzyme Activation; Enzyme Activators; Fluoxetine; Histamine; Phenylalanine; Selective Serotonin Reuptake Inhibitors; Sertraline; Structure-Activity Relationship | 2003 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Fluorescent reporters of monoamine transporter distribution and function.
Topics: Animals; Blood Pressure; Cell Line; Fluorescent Dyes; Isoquinolines; Mice; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Spectrophotometry, Ultraviolet | 2011 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Body Temperature; Citalopram; Drug Interactions; Exploratory Behavior; Fenfluramine; Male; Motor Activity; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Sertraline; Tetrahydronaphthalenes | 1992 |
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine | 1992 |
Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration.
Topics: 1-Naphthylamine; Animals; Citalopram; Hippocampus; Imipramine; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Time Factors | 1995 |
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes | 1994 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal | 1997 |
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Exacerbation of respiratory symptoms in patients with panic disorder.
Topics: 1-Naphthylamine; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cilazapril; Citalopram; Comorbidity; Drug Interactions; Female; Humans; Hypertension; Male; Middle Aged; Panic Disorder; Respiration Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
An affinity-modulating site on neuronal monoamine transport proteins.
Topics: 1-Naphthylamine; Animals; Binding Sites; Biogenic Monoamines; Cerebral Cortex; Citalopram; Corpus Striatum; Female; Fluoxetine; In Vitro Techniques; Kinetics; Neurons; Piperazines; Rats; Receptors, Neurotransmitter; Sertraline; Stereoisomerism | 1997 |
Pica and the obsessive-compulsive spectrum disorders.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Citalopram; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pica; Sertraline; Tomography, Emission-Computed, Single-Photon | 1996 |
Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
Topics: 1-Naphthylamine; Citalopram; Drug Monitoring; Gas Chromatography-Mass Spectrometry; Humans; Paroxetine; Quality Control; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 1998 |
Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
Topics: Adolescent; Adult; Child; Citalopram; Cytochrome P-450 Enzyme System; Drug Prescriptions; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline.
Topics: Animals; Biogenic Monoamines; Cerebral Cortex; Citalopram; Clozapine; Corpus Striatum; Diazepam; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; GABA Agents; Male; Norepinephrine; Nucleus Accumbens; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1999 |
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride | 1999 |
Excretion of paroxetine into breast milk.
Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides | 1999 |
[Severe withdrawal symptoms with fever upon stopping paroxetine].
Topics: Citalopram; Drug Administration Schedule; Fever; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1999 |
Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis.
Topics: Citalopram; Electrophoresis, Capillary; Fluoxetine; Fluvoxamine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Serotonin syndrome after small doses of citalopram or sertraline.
Topics: Citalopram; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2000 |
[The transfer of selective serotonin reuptake inhibitors to human milk].
Topics: Antidepressive Agents; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Milk, Human; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Forced titration as a confound in an SSRI comparator study of sertaline versus citalopram in the treatment of major depressive disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents; Cells, Cultured; Chloride Channels; Citalopram; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluvoxamine; Humans; Hydrogen-Ion Concentration; Hypotonic Solutions; Inhibitory Concentration 50; Membrane Potentials; Paroxetine; Patch-Clamp Techniques; Pulmonary Artery; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.
Topics: Citalopram; Clinical Pharmacy Information Systems; Cost Control; Cost Savings; Drug Administration Schedule; Drug Costs; Drug Utilization; Fluoxetine; Fluvoxamine; Hospital Costs; Hospitals, Veterans; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2003 |
Burning mouth syndrome as a side effect of SSRIs.
Topics: Burning Mouth Syndrome; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Placental passage of antidepressant medications.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fetal Blood; Fluoxetine; Humans; Maternal-Fetal Exchange; Paroxetine; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sertraline | 2003 |
The effect of combined administration of ethanol and sertraline, fluoxetine and citalopram on rabbit EEG.
Topics: Analysis of Variance; Animals; Brain; Citalopram; Electroencephalography; Ethanol; Female; Fluoxetine; Male; Rabbits; Sertraline | 2003 |
Selective serotonin reuptake inhibitors in pilot fatalities of civil aviation accidents, 1990-2001.
Topics: Accidents, Aviation; Aerospace Medicine; Certification; Citalopram; Databases as Topic; Environmental Monitoring; Fluoxetine; Humans; Paroxetine; Postmortem Changes; Selective Serotonin Reuptake Inhibitors; Sertraline; Survival Rate; United States | 2003 |
Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Biogenic Monoamines; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Citalopram; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Sertraline; Tissue Distribution | 2004 |
A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment charges.
Topics: Adolescent; Adult; Aged; Citalopram; Cohort Studies; Costs and Cost Analysis; Depression; Female; Humans; Male; Middle Aged; Patient Compliance; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Topics: Adult; Benzylamines; Carbon Radioisotopes; Carrier Proteins; Citalopram; Corpus Striatum; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2004 |
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Dopamine beta-Hydroxylase; Droxidopa; Fluoxetine; Gene Deletion; Mice; Morpholines; Norepinephrine; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tail | 2004 |
Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.
Topics: Citalopram; Depressive Disorder; Drug Administration Schedule; Fatigue; Fluoxetine; Humans; Paroxetine; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Neonatal complications after intrauterine exposure to SSRI antidepressants.
Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Repetition of serotonin syndrome after reexposure to SSRI--a case report.
Topics: Citalopram; Depressive Disorder, Major; Female; Humans; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2004 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.
Topics: Animals; Citalopram; Cladocera; Ecosystem; Female; Fluoxetine; Fluvoxamine; Lethal Dose 50; Male; No-Observed-Adverse-Effect Level; Paroxetine; Reproduction; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests, Acute; Toxicity Tests, Chronic; Water Pollutants, Chemical | 2004 |
Binding of S-citalopram and paroxetine discriminates between species.
Topics: Animals; Benzylamines; Binding, Competitive; Brain; Cells, Cultured; Chickens; Citalopram; Evolution, Molecular; Humans; Isoquinolines; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Radioligand Assay; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Species Specificity; Tritium | 2005 |
The emergence of tics during escitalopram and sertraline treatment.
Topics: Citalopram; Drug Therapy, Combination; Female; Humans; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Tics | 2005 |
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Anxiety Disorders; Citalopram; Cohort Studies; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Patient Dropouts; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2005 |
Adolescents' response to antidepressant treatment in a community mental health center.
Topics: Adolescent; Adolescent Psychiatry; Algorithms; Antidepressive Agents; Child; Child Psychiatry; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Microchemistry; Mirtazapine; Piperazines; Reproducibility of Results; Sertraline | 2005 |
Response to SSRI-induced enuresis: a case report.
Topics: Adult; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Enuresis; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.
Topics: Calibration; Chemical Fractionation; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Fluvoxamine; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sewage; Water Pollutants, Chemical | 2006 |
Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report.
Topics: Adult; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Dyskinesias; Humans; Male; Mental Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.
Topics: Adolescent; Adult; Anxiety Disorders; Citalopram; Cohort Studies; Cost Sharing; Databases, Factual; Depression; Drug Prescriptions; Female; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2006 |
Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs).
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Alopecia; Bayes Theorem; Citalopram; Female; Humans; Male; Middle Aged; Pharmacoepidemiology; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sweden; World Health Organization | 2006 |
Delirium in HIV-associated dementia.
Topics: Adolescent; AIDS Dementia Complex; Antipsychotic Agents; Brain; Citalopram; Cytochrome P-450 CYP2D6 Inhibitors; Delirium; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Risperidone; Ritonavir; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2006 |
Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Citalopram; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2006 |
Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.
Topics: Adolescent; Adult; Aged; Catchment Area, Health; Citalopram; Cost-Benefit Analysis; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Health Expenditures; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Spain | 2006 |
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder.
Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Decision Support Techniques; Depressive Disorder; Diarrhea; Drug Costs; Erectile Dysfunction; Female; Headache; Humans; Male; Monte Carlo Method; Nausea; Office Visits; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders | 2007 |
Treatment of depression in patients with coronary artery disease.
Topics: Aged; Citalopram; Coronary Artery Disease; Depressive Disorder, Major; Humans; Middle Aged; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome | 2008 |
Post-traumatic stress disorder in an elderly combat veteran: a case report.
Topics: Age Factors; Aged, 80 and over; Citalopram; Humans; Male; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Veterans; Warfare; World War II | 2007 |
Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.
Topics: Child; Citalopram; Female; Fluvoxamine; Humans; Male; Mental Disorders; Nocturnal Enuresis; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
[(3)H] citalopram binding to serotonin transporter sites in minnow brains.
Topics: Animals; Brain; Chlorpyrifos; Cholinesterase Inhibitors; Citalopram; Cyprinidae; Desipramine; Dopamine Uptake Inhibitors; Male; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2007 |
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Motor Activity; Paroxetine; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sertraline; Species Specificity; Swimming | 2008 |
Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
Topics: Aged; Aged, 80 and over; Algorithms; Bayes Theorem; Citalopram; Cost-Benefit Analysis; Depression; Drugs, Generic; Female; Fluoxetine; Humans; Male; Medicare; Models, Statistical; Paroxetine; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2007 |
Augmentation strategies to increase antidepressant efficacy.
Topics: Algorithms; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Drug Synergism; Humans; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years.
Topics: Adult; Age Distribution; Age Factors; Aged; Antidepressive Agents; Citalopram; Cognition Disorders; Comorbidity; Depressive Disorder; Depressive Disorder, Major; Disability Evaluation; Drug Utilization; Geriatric Assessment; Humans; Longitudinal Studies; Middle Aged; Multivariate Analysis; Netherlands; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2008 |
Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.
Topics: Animals; Citalopram; Male; Mice; Models, Biological; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 2008 |
Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Mice, Inbred CBA; Models, Animal; Morpholines; Motor Activity; Nomifensine; Piperidines; Pyrazoles; Reboxetine; Receptor, Cannabinoid, CB1; Rimonabant; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2008 |
[Sleep spindles in post traumatic stress disorder: significant importance of selective serotonin reuptake inhibitors].
Topics: Citalopram; Electromyography; Electrooculography; Humans; Paroxetine; Reference Values; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep, REM; Stress Disorders, Post-Traumatic; Wakefulness | 2008 |
Dextromethorphan-induced serotonin syndrome.
Topics: Antitussive Agents; Child; Citalopram; Dextromethorphan; Drug Interactions; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Treatment Outcome; Young Adult | 2008 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Fast separation of selective serotonin reuptake inhibitors antidepressants in plasma sample by nonaqueous capillary electrophoresis.
Topics: Antidepressive Agents; Citalopram; Drug Monitoring; Electrophoresis, Capillary; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.
Topics: Adult; Aged; Antidepressive Agents; Biomarkers; Citalopram; Depression; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2009 |
Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Female; Fluoxetine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Postpartum Period; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Sertraline; Venlafaxine Hydrochloride | 2010 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted | 2010 |
Affective and anxiety disorders: prevalence, treatment and antidepressant medication use.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Australia; Citalopram; Cross-Sectional Studies; Depressive Disorder; Drug Utilization; Female; Health Surveys; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Statistical Distributions; Young Adult | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Environmental risk assessment of three selective serotonin reuptake inhibitors in the aquatic environment: a case study including a cocktail scenario.
Topics: Biodegradation, Environmental; Citalopram; Environmental Monitoring; Fluoxetine; Fresh Water; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical | 2011 |
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2010 |
Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment.
Topics: Acetamides; Anti-Infective Agents; Citalopram; Drug Interactions; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pain; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Staphylococcal Infections; Tremor | 2010 |
Allergic reactions--outcome of sertraline and escitalopram treatments.
Topics: Adult; Angioedema; Antidepressive Agents; Citalopram; Combined Modality Therapy; Drug Eruptions; Drug Hypersensitivity; Dysthymic Disorder; Female; Humans; Psychotherapy; Psychotherapy, Group; Sertraline | 2011 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Evidence-Based Medicine; Female; Fluoxetine; Humans; Odds Ratio; Paroxetine; Physicians, Family; Pregnancy; Pregnancy Complications; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2011 |
Biomarkers of anhedonic-like behavior, antidepressant drug refraction, and stress resilience in a rat model of depression.
Topics: Anhedonia; Animals; Biomarkers; Citalopram; Depression; Disease Models, Animal; Drug Resistance; Eating; Gene Expression Profiling; Hippocampus; Humans; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Sucrose | 2011 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochondriasis; Hysteria; Male; Middle Aged; MMPI; Neurotic Disorders; Observer Variation; Paroxetine; Psychometrics; Reproducibility of Results; Sertraline; Statistics as Topic; Young Adult | 2011 |
Discerning the effects of psychopathology and antidepressant treatment on sexual dsyfunction*.
Topics: Adult; Case-Control Studies; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Female; Humans; Male; Prevalence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome; Turkey; Young Adult | 2013 |
Comparison of two extraction methods for the determination of selective serotonin reuptake inhibitors in sewage sludge by hollow fiber liquid-phase microextraction.
Topics: Chromatography, Liquid; Citalopram; Fluoxetine; Liquid Phase Microextraction; Mass Spectrometry; Paroxetine; Porosity; Selective Serotonin Reuptake Inhibitors; Sertraline; Sewage; Surface Properties | 2012 |
Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Models, Economic; Quality of Life; Sertraline; Thailand; Venlafaxine Hydrochloride | 2012 |
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride | 2012 |
In vivo evaluation of [¹²³I]mZIENT as a SPECT radioligand for the serotonin transporter.
Topics: Animals; Binding, Competitive; Citalopram; Female; Iodine Radioisotopes; Ligands; Nortropanes; Papio; Reproducibility of Results; Serotonin Plasma Membrane Transport Proteins; Sertraline; Substrate Specificity; Tomography, Emission-Computed, Single-Photon | 2012 |
In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Blood Coagulation; Blood Platelets; Citalopram; Cyclohexanols; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Platelet Adhesiveness; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2012 |
Danish physicians' preferences for prescribing escitalopram over citalopram and sertraline to treatment-naïve patients: a national, register-based study.
Topics: Adolescent; Adult; Citalopram; Denmark; Drug Utilization; General Practitioners; Humans; Physicians; Practice Patterns, Physicians'; Psychiatry; Registries; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model.
Topics: Anhedonia; Animals; Citalopram; Depression; Disease Models, Animal; Hippocampus; Immune System; Laser Capture Microdissection; Male; Protein Processing, Post-Translational; Proteins; Proteomics; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction; Stress, Psychological; Tandem Mass Spectrometry; Two-Dimensional Difference Gel Electrophoresis | 2012 |
Effect of fluoxetine and adenosine receptor NECA agonist on G alpha q/11 protein of C6 glioma cells.
Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Neoplasms; Cell Line, Tumor; Citalopram; Depression; Fluoxetine; Glioma; GTP-Binding Protein alpha Subunits, Gq-G11; Neurons; Purinergic P1 Receptor Agonists; Rats; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction | 2012 |
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Citalopram; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Emotions; Facial Expression; Female; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Sertraline; Triazines; Valproic Acid | 2013 |
A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; Young Adult | 2013 |
Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population.
Topics: Age Factors; Aged; Antidepressive Agents; Citalopram; Comparative Effectiveness Research; Depression; Health Expenditures; Humans; Insurance Claim Review; Medicare; Medication Adherence; Racial Groups; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 2012 |
The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Canada; Child; Child, Preschool; Citalopram; Databases, Factual; Fluoxetine; Fluvoxamine; Humans; Infant; Mental Disorders; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Citalopram; Depressive Disorder; Female; Heart Diseases; Humans; Male; Middle Aged; Mortality; Proportional Hazards Models; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Food and Drug Administration | 2013 |
Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials.
Topics: Acoustic Stimulation; Adult; Brain; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Hypnotics and Sedatives; Loudness Perception; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Dysfunction, Physiological | 2014 |
Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Enlargement; Cells, Cultured; Citalopram; Dendrites; Fluoxetine; Hippocampus; Imipramine; Nerve Tissue Proteins; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Sertraline; Thiazepines; Tranylcypromine | 2014 |
Penicillin G as a novel chiral selector in capillary electrophoresis.
Topics: Anti-Bacterial Agents; Benzofurans; Citalopram; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Methanol; Metoprolol; Penicillin G; Propranolol; Pyrrolidines; Sertraline; Solubility; Stereoisomerism; Temperature | 2014 |
Use of SSRIs among Danish children: a nationwide study.
Topics: Adolescent; Age Distribution; Antipsychotic Agents; Child; Child, Preschool; Citalopram; Denmark; Depression; Drug Prescriptions; Drug Utilization Review; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Prevalence; Registries; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Enantiomer separations of basic chiral compounds by capillary electrochromatography on a phosphated β-cyclodextrin-modified zirconia monolith.
Topics: Atenolol; beta-Cyclodextrins; Buffers; Capillary Electrochromatography; Citalopram; Hydrogen-Ion Concentration; Metoprolol; Sertraline; Stereoisomerism; Zirconium | 2014 |
Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline.
Topics: Adult; Aged; Aged, 80 and over; Citalopram; Drug Interactions; Female; Half-Life; Humans; Male; Middle Aged; Proton Pump Inhibitors; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2015 |
The development and validation of a turbulent flow-liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum.
Topics: Antidepressive Agents; Bupropion; Chromatography, Liquid; Citalopram; Drug Stability; Humans; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Solid Phase Extraction; Tandem Mass Spectrometry | 2014 |
Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
Topics: Adult; Citalopram; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Prospective Studies; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Child; Citalopram; Databases, Factual; Drug Monitoring; Drug Utilization; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2015 |
Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Topics: Adult; Asia, Eastern; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Pain; Paroxetine; Prospective Studies; Quality of Life; Regression Analysis; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2016 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
Topics: Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Citalopram; Estradiol; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Progesterone; Selective Serotonin Reuptake Inhibitors; Sertraline; Testosterone | 2015 |
Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here?
Topics: Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Sertraline | 2015 |
Topiramate augmentation in a patient with obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Citalopram; Drug Synergism; Fear; Female; Fructose; Humans; Lorazepam; Obsessive-Compulsive Disorder; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate; Treatment Refusal | 2015 |
Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Citalopram; Cyclopropanes; Duloxetine Hydrochloride; Fluvoxamine; Hep G2 Cells; Humans; Liver Neoplasms; Milnacipran; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline | 2015 |
Citalopram and sertraline exposure compromises embryonic bone development.
Topics: Animals; Apoptosis; Bone and Bones; Calcification, Physiologic; Cartilage; Cells, Cultured; Citalopram; Disease Models, Animal; Humans; Mesenchymal Stem Cells; Osteoblasts; Osteogenesis; Selective Serotonin Reuptake Inhibitors; Sertraline; Zebrafish | 2016 |
Cardiac Toxicity in Selective Serotonin Reuptake Inhibitor Users.
Topics: Case-Control Studies; Citalopram; Female; Fibrosis; Humans; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2015 |
Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.
Topics: Adolescent; Adult; Antidepressive Agents; Child; Child, Preschool; Citalopram; Cohort Studies; Databases, Factual; Depression; Dose-Response Relationship, Drug; Drug Labeling; Drug Prescriptions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Suicide, Attempted; United States; United States Food and Drug Administration; Young Adult | 2016 |
Time-course of serotonin transporter occupancy by single dose of three SSRIs in human brain: A positron emission tomography study with [(11)C]DASB.
Topics: Adult; Benzylamines; Brain; Carbon Radioisotopes; Citalopram; Dose-Response Relationship, Drug; Female; Humans; Male; Paroxetine; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Young Adult | 2016 |
Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
Topics: Adult; Aged; Brazil; Citalopram; Electrocardiography; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors.
Topics: Adult; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2016 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
Which SSRIs most effectively treat depression in adolescents?
Topics: Adolescent; Adolescent Behavior; Antidepressive Agents; Behavior Therapy; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Antidepressant Medication Prescribing Practices for Treatment of Major Depressive Disorder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Drug Prescriptions; Female; Humans; Insurance, Health; Male; Middle Aged; Practice Patterns, Physicians'; Sertraline; Trazodone; United States; Young Adult | 2017 |
Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report.
Topics: Adult; Alopecia; Anxiety Disorders; Citalopram; Female; Humans; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms.
Topics: Animals; Citalopram; Fluoxetine; Mice; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Synaptosomes | 2017 |
A comparative study of QT prolongation with serotonin reuptake inhibitors.
Topics: Adult; Aged; Arrhythmias, Cardiac; Citalopram; Databases, Factual; Female; Fluvoxamine; Humans; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacovigilance; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Improvements in Quality-Adjusted Life Years and Cost-Utility After Pharmacotherapy for Premenstrual Dysphoric Disorder: A Retrospective Study.
Topics: Adolescent; Adult; Citalopram; Cost-Benefit Analysis; Female; Humans; Middle Aged; Premenstrual Dysphoric Disorder; Quality-Adjusted Life Years; Retrospective Studies; Sertraline; Young Adult | 2018 |
Assessing Responsiveness of Health Systems to Drug Safety Warnings.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Drug Labeling; Drug Prescriptions; Female; Hospitals, Veterans; Humans; Long QT Syndrome; Male; Middle Aged; Sertraline; United States; United States Food and Drug Administration; Young Adult | 2018 |
Reference Brain/Blood Concentrations of Citalopram, Duloxetine, Mirtazapine and Sertraline.
Topics: Antidepressive Agents; Brain; Calibration; Cause of Death; Chromatography, Liquid; Citalopram; Drug Overdose; Duloxetine Hydrochloride; Forensic Toxicology; Humans; Linear Models; Mianserin; Mirtazapine; Reference Standards; Reproducibility of Results; Sertraline; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2018 |
Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Topics: Altitude Sickness; Animals; Antidepressive Agents; Brain; Citalopram; Dopamine; Female; Fluoxetine; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Electrocardiogram Monitoring After the Food and Drug Administration Warnings for Citalopram: Unheeded Alerts?
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Citalopram; Drug Monitoring; Electrocardiography; Female; Humans; Interrupted Time Series Analysis; Male; Medicare; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Department of Veterans Affairs; United States Food and Drug Administration | 2018 |
Antidepressants in breast milk; comparative analysis of excretion ratios.
Topics: Adult; Antidepressive Agents; Breast Feeding; Child Development; Citalopram; Depression; Female; Humans; Infant; Milk, Human; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2019 |
Social media and smartphone technology in the symptomatology of OCD.
Topics: Adult; Citalopram; Female; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Smartphone; Social Media | 2018 |
The relationship between the serotonin 2A receptor gene -1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Female; Genotype; Humans; Male; Nausea; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Sertraline; Vomiting; Young Adult | 2018 |
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Citalopram; Epithelial Cells; Fluoxetine; Paroxetine; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Sertraline; Swine | 2018 |
Segmental Hair Analysis-Interpretation of the Time of Drug Intake in Two Patients Undergoing Drug Treatment.
Topics: Acetaminophen; Adult; Analgesics; Antiemetics; Azabicyclo Compounds; Citalopram; Female; Forensic Toxicology; Hair; Humans; Hypnotics and Sedatives; Metoclopramide; Morphine; Oxazepam; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sumatriptan; Tramadol; Vasoconstrictor Agents | 2019 |
Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
Topics: Aged; Citalopram; Databases, Factual; Drug Utilization; Drugs, Generic; Female; Humans; Insurance Claim Review; Insurance, Health; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2019 |
A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression.
Topics: Adult; Aged; Aged, 80 and over; Animals; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Receptors, Serotonin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2020 |
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, Cardiac; Depression; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peroxidase; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 2019 |
Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence.
Topics: Citalopram; Databases, Factual; Drugs, Generic; Humans; Paroxetine; Practice Patterns, Physicians'; Prescription Fees; Scotland; Selective Serotonin Reuptake Inhibitors; Sertraline; State Medicine | 2019 |
Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; C-Reactive Protein; Citalopram; Cohort Studies; Cytokines; Depression; Depressive Disorder; Female; Humans; Interleukin-12; Interleukin-6; Male; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.
Topics: Animals; Cell Line; Cell Movement; Cell Proliferation; Citalopram; Drosophila; Drug Evaluation, Preclinical; Humans; Membrane Proteins; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Diseases; Mutation; Myoblasts; Receptor, Notch1; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction; Zebrafish | 2019 |
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Paroxetine; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2019 |
Serotonin and serotonin reuptake inhibitors alter placental aromatase.
Topics: Aromatase; Cells, Cultured; Citalopram; Female; Fluoxetine; Humans; Molecular Docking Simulation; Paroxetine; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Trophoblasts; Venlafaxine Hydrochloride | 2019 |
A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.
Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Labeling; Humans; Marketing of Health Services; Pharmacogenetics; Pharmacogenomic Testing; Precision Medicine; Sertraline | 2020 |
Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
Topics: Adolescent; Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Sexual Dysfunction, Physiological; Young Adult | 2020 |
The teratogenic effects of sertraline in mice.
Topics: Animals; Citalopram; Female; Humans; Mice; Mice, Inbred ICR; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2020 |
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2020 |
Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.
Topics: Citalopram; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2020 |
Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.
Topics: Abortion, Spontaneous; Adult; Citalopram; Female; Fertility; Fluoxetine; Humans; Live Birth; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; United States; Young Adult | 2020 |
Sertraline and Citalopram Actions on Gut Barrier Function.
Topics: Animal Feed; Animals; Citalopram; Diet; Dietary Proteins; Gene Expression Regulation; Humans; Intestinal Mucosa; Intestines; Male; Permeability; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Physiological; Zonula Occludens-1 Protein | 2021 |
Low SSRI dosing in clinical practice-a register-based longitudinal study.
Topics: Child; Citalopram; Fluoxetine; Humans; Longitudinal Studies; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
Topics: Affect; Aged; Aged, 80 and over; Aging; Antidepressive Agents; Brain; Citalopram; Depressive Disorder, Major; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2021 |
Gelatin microsphere coated Fe
Topics: Adsorption; Antidepressive Agents, Tricyclic; Citalopram; Desipramine; Gelatin; Graphite; Humans; Limit of Detection; Magnetic Phenomena; Magnetite Nanoparticles; Microspheres; Nanocomposites; Quantum Dots; Sertraline; Solid Phase Extraction | 2021 |
Molecular imaging of beta-amyloid deposition in late-life depression.
Topics: Age Factors; Aged; Alzheimer Disease; Amyloid beta-Peptides; Antidepressive Agents, Second-Generation; Citalopram; Dementia; Depression; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Sertraline | 2021 |
Side Effect Profiles of Selective Serotonin Reuptake Inhibitors: A Cross-Sectional Study in a Naturalistic Setting.
Topics: Antidepressive Agents; Citalopram; Cross-Sectional Studies; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
27-year-old woman • postpartum seizures • PTSD • history of depression • Dx?
Topics: Adult; Antidepressive Agents; Bupropion; Citalopram; Depression, Postpartum; Female; Humans; Seizures; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome | 2021 |
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Comparison of the effect of citalopram, bupropion, sertraline, and tricyclic antidepressants on QTc: A cross-sectional study.
Topics: Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study.
Topics: Aged; Antidepressive Agents; Australia; Case-Control Studies; Central Nervous System; Citalopram; Delirium; Fluvoxamine; Humans; Mirtazapine; Nitrazepam; Risk Factors; Sertraline; Venlafaxine Hydrochloride | 2022 |
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; COVID-19; Cytokines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Prescription Drugs; Retrospective Studies; Risk; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; United States | 2021 |
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.
Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P450 Family 2; Drug Interactions; Humans; Paroxetine; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults.
Topics: Aged; Antidepressive Agents; Citalopram; Humans; Logistic Models; Medicare; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2022 |
Complex Effects of Sertraline and Citalopram on In Vitro Murine Breast Cancer Proliferation and on In Vivo Progression and Anxiety Level.
Topics: Animals; Anxiety; Cell Proliferation; Citalopram; Mice; Neoplasms; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Death, Sudden, Cardiac; Escitalopram; Humans; Proton Pump Inhibitors; Renal Dialysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Humans; Italy; Paroxetine; Retrospective Studies; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels | 2022 |
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Potassium; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2022 |
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Paroxetine; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2022 |
Graphical methods for understanding changes in states: Understanding medication use pathways.
Topics: Aged; Antidepressive Agents; Citalopram; Humans; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
Topics: Adolescent; Antipsychotic Agents; Citalopram; Diabetes Mellitus, Type 2; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2022 |
Occurrence and removal of psychiatric pharmaceuticals in the Tehran South Municipal Wastewater Treatment Plant.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Citalopram; Environmental Monitoring; Humans; Hypnotics and Sedatives; Iran; Pharmaceutical Preparations; Sertraline; Thioridazine; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2023 |
Nontarget screening based on molecular networking strategy to identify transformation products of citalopram and sertraline in wastewater.
Topics: Citalopram; Sertraline; Wastewater; Water Pollutants, Chemical | 2023 |
FKBP5 blockade may provide a new horizon for the treatment of stress-associated disorders: An in-silico study.
Topics: Citalopram; Clomipramine; Duloxetine Hydrochloride; Fluoxetine; Humans; Sertraline; United States | 2023 |
Chemical Imaging of Pharmaceuticals in Biofilms for Wastewater Treatment Using Secondary Ion Mass Spectrometry.
Topics: Biofilms; Citalopram; Humans; Ketoconazole; Pharmaceutical Preparations; Sertraline; Spectrometry, Mass, Secondary Ion; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2023 |
Do sociodemographic and clinical factors affect the selection of initial antidepressant treatment for depression in older adults? Results from a nationwide descriptive study in Denmark.
Topics: Aged; Antidepressive Agents; Citalopram; Cross-Sectional Studies; Denmark; Depression; Escitalopram; Humans; Mirtazapine; Sertraline | 2023 |
Fetal SSRI antidepressant exposure and infant sleep: Findings from the MPEWS pregnancy cohort study.
Topics: Antidepressive Agents; Citalopram; Cohort Studies; Escitalopram; Female; Humans; Infant; Longitudinal Studies; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep | 2023 |
Contamination of water, soil, and plants by micropollutants from reclaimed wastewater and sludge from a wastewater treatment plant.
Topics: Carbamazepine; Citalopram; Gabapentin; Humans; Sertraline; Sewage; Soil; Soil Pollutants; Telmisartan; Tramadol; Vegetables; Venlafaxine Hydrochloride; Wastewater; Water | 2024 |